Opsoclonus-Myoclonus–Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?
In this clinical quandary, investigators determine how to best treat patients with opsoclonus-myoclonus–associated neuroblastoma with bone marrow metastases.
COLOMATE Challenge to Overcome Resistance in Metastatic Colorectal Cancer
Takayuki Yoshino, MD, PhD gives his perspective on the COLMATE trial and what it's done to help patients overcome colorectal cancer.
Addressing Resistance to Targeted Therapies in Metastatic Colorectal Cancer
Investigators discuss the use of targeted therapies to treat metastatic colorectal cancer.
An Evolving Relationship Between Medical Oncologists and Genetic Counselors in Prostate Cancer
Jun Gong, MD, gives his perspective on a review article published in ONCOLOGY about the necessary relationship between medical oncologists and genetic counselors to help treat patients with prostate cancer.
Germline Testing in Prostate Cancer: When and Who to Test
Results of multiple studies have shown that a proportion of men with advanced prostate cancer carry germline DNA damage repair mutations. This article summarizes recommendations for germline testing in prostate cancer and describes care models for providing counseling and testing.
Clinically Meaningful Outcome Measures: A Role for Geriatric Assessment
Nora Kovar, MD, MPH; and Melissa L. Teply, MD, give their perspective on research from Quirin Zangl, MD, published in ONCOLOGY regarding geriatric assessment in patients with genitourinary carcinoma.
Value of Geriatric Assessment in Patients With Genitourinary Carcinoma
This work from Quirin Zangl, MD, and colleagues to evaluate comprehensive geriatric assessment tools to better guide patients with urogenital carcinomas perioperatively and, consequently, to intensify or reduce hospital resource use.
Physician Burnout May Correlate With Institutional Practices
Samuel Edwards, MD, discusses the science behind physician burnout and how it can be prevented.
Expert Commentary on the Product Profile of Umbralisib for Lymphoma
In an interview with ONCOLOGY®, Douglas Braun, CSP, PharmD, RPh, offers a comprehensive review of real-world treatment considerations of umbralisib as therapy for patients with previously treated follicular and marginal zone lymphoma.
Modern Treatment Standards Require State-of-the-Art Molecular Profiling
“In my mind, the question is not who should get chemotherapy, but who can avoid chemotherapy in this day and age.”
ONCOLOGY Remembers Dr Franco Muggia
ONCOLOGY remembers Dr Franco Muggia's contribution to cancer care.
2 Clarke Drive Cranbury, NJ 08512